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Renal cell cancer rarely metastasizes to the thyroid gland, and it has been reported to
present as a solitary mass. We present a case of diffuse thyroid cancer metastases from
renal cell cancer. Bilateral internal jugular vein tumor thrombi were also present. To the
best of our knowledge, this is the first description of diffuse thyroid metastases from renal
cell cancer in the English literature. Renal cell cancer metastases should be considered in
the differential of thyroid imaging abnormalities arising in the setting of known renal cell
carcinoma, particularly late in the course of disease. This is frequently associated with
internal jugular vein thrombi, which should be evaluated with an abnormal thyroid.
Thyroglobulin levels are usually normal in such patients.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Renal cell carcinoma (RCC) accounts for 2%-3% of all
malignant diseases in adults [1] and is responsible for 2.4%
of all cancer deaths each year [1]. It is the seventh most
common cancer in men and the ninth most common in
women [1]. Clear-cell RCC is the most common subtype of
RCC, occurring in about 7 of 10 people with RCC [2]. The
metastatic pathways for RCC are not always foreseeable,
but most common sites of metastases include lungs, brain,
bone and/or bone marrow [1]. Metastatic involvement of the
thyroid gland from RCC is extremely rare [3e7]. RCC me-
tastases to the thyroid gland have been previously reported
as a solitary mass only, without report of diffuse metastaticlared that no competing i
. Jha).
Elsevier Inc. under copy
se (http://creativecommoinvolvement in the existing literature [3,4,6]. To the best of
our knowledge, this is the first description diffuse thyroid
cancer metastasis from renal cell cancer, in the English
literature.Case report
An87-year-oldmanpresented for annual surveillancepositron
emission tomography computed tomography (fluro deoxy-
glucose [FDG]-PET/CT) for evaluation of metastatic renal cell
cancer in remission. Thepatient had left nephrectomy10 years
ago and the last surveillance examinationdid not demonstrate
any evidence of recurrent disease (Fig. 1A). At the FDG-positronnterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e Comparative positron emission tomography computed tomography images demonstrating initial findings
(A) and that at subsequent (B) annual surveillance. Maximal intensity projection (MIP), fused axial image, attenuation-
corrected PET image and computed tomography images are presented. (A) One year ago, the patient had a normal-sized
thyroid with expected low-level fluro deoxyglucose uptake. (B) At one-year surveillance follow-up, the patient developed
marked thyroid enlargement with avid fluro deoxyglucose uptake. MIP images also demonstrate linear increased uptake
in brachiocephalic vein (arrow).
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metabolic pulmonary nodules were identified suspicious for
new metastatic disease. Interval development of diffusely
increased activity in a newly enlarged thyroid gland was con-
cerning for malignancy (Fig. 1). No focal lesions were present.
Abnormal activity was noted in bilateral jugular veins and
brachiocephalic vein. The patient was referred to ultrasound,
where in the thyroid again demonstrated to be diffusely
enlarged, markedly heterogeneous and hypervascular,
without focal lesions (Fig. 2). At the time of the ultrasound,
thrombiwere noted in bilateral internal jugular veins. On color
Doppler interrogation, internal vascular flowwasnotedwithin
these thrombi, which demonstrated arterial waveforms on
spectral Doppler interrogation (Fig. 3). In addition, thrombus
material could be traced in the internal thyroid vein, in conti-
guity with the tumor thrombus in the jugular veins (Fig. 2). On
the basis of clinical scenario, heterogeneous nonemass-like
enlargement, the absence of calcifications, bilateral tumor
thrombi, andanormal thyroglobulin level andmetastatic renal
cell cancer was suspected. Subsequently, a nontargeted thy-
roid fine-needle aspiration was performed, which demon-
strated metastatic clear-cell renal cell cancer, with cells
containing clear “bubbly” cytoplasm and round and distinctnucleoli (Fig. 4). Immunohistochemical stain demonstrated
CD10 and RCC positivity and negative for TTF-1 and SOX-10.Discussion
Metastatic involvement of the thyroid gland has been rarely
reported. In a recently published series, less than 0.2% of all
biopsied thyroid nodules result in detection of metastatic
disease [5]. On an autopsy series, this number has been re-
ported to be around 1.25%-24%, depending on the wide-
spread nature of disease [8]. Although renal cell cancer very
rarely metastasizes to the thyroid gland, it is the most
common malignancy leading to thyroid metastases [5,7]. It
has been reported to constitute one-third to half of all the
causes for thyroid metastases [5,7]. This has most commonly
been reported to occur late in the disease, with a mean in-
terval of 7.5 years after initial diagnosis [4]. According to
Duggal et al. [4], almost 150 cases of clinically recognized
metastatic RCC to the thyroid have been reported in the
English language literature. Clear-cell variant of RCC has
been reported to most commonly metastasize to the thyroid
as well [3e6].
Fig. 2 e (A) Transverse ultrasound image of the thyroid
demonstrates an enlarged gland with a markedly
heterogeneous appearance. No discrete thyroid nodules
are identified. (B) Focused evaluation of right thyroid lobe
redemonstrates these findings. Also seen is soft tissue
distending the inferior thyroidal vein (ITV) and right
internal jugular vein (Rt IJV). (C) Color Doppler interrogation
shows markedly increased vascularity throughout the
right lobe of the thyroid.
Fig. 3 e (A) Transverse and (B) longitudinal ultrasound
images of the right neck demonstrate soft tissue within the
right internal jugular vein. (C) On Color Doppler
interrogation, internal flow is demonstrated within the
thrombus. (D) Spectral interrogation reveals arterial
waveforms, within the thrombus, highly suspicious for
tumor thrombus.
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patient was initially diagnosed with clear-cell RCC approxi-
mately 10 years ago and had a long disease-free interval
before recurrence. Disease recurrence was seen with devel-
opment of pulmonary and thyroid metastases. The patient
also had normal thyroglobulin levels with only mild elevated
thyroid stimulating hormone. However, our case is unique
Fig. 4 e Cytology specimen from nontargeted fine-needle
aspiration from the thyroid demonstrates cells with clear,
bubbly cytoplasm, and round nuclei with distinct nucleoli.
Immunohistochemical stains were positive for CD10 and
RCC markers and negative for TTF-1 and SOX-10 markers
(thyroid cancer markers).
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from RCC, where solid masses were described without the
report of diffuse metastatic involvement of the thyroid gland.
In fact, Kobayashi et al [9] have proposed that presence of
diffuse thyroid involvement argues against the presence of
metastasis. Also the presence of tumor thrombus in bilateral
internal jugular veins, and extension into the brachiocephalic
veins in our case is unique and of significant interest.
Metastases should be suspected in cases of thyroidmass in
a patient with known history of RCC. Although this will
most commonly present as a solid mass, diffuse metastatic
involvement can also be seen. RCC metastases should partic-
ularly be suspected if there is vascular invasion. Although
vascular invasion is awell-documentedmicroscopic feature of
poorly differentiated thyroid cancer, less than 10 cases pre-
senting gross intraluminal invasion of the internal jugular
vein have been reported. Gardner et al. [10] have reported an
approximate incidence of 1.5% of extrathyroidal vascular
invasion with thyroid cancer. On the other hand, renal vein
invasion with RCC is extremely common. Given this high
propensity of vascular invasion with RCC, if vascular invasion
is present with a thyroid mass in a patient with knownRCC, then this should raise the suspicion for metastatic dis-
ease over a primary thyroid malignancy.Conclusions
In conclusion, if patients have a known history of renal cell
cancer with thyroid mass or nonemass-like imaging abnor-
malities, metastases should be considered in the differential
of this mass. Thyroid function tests will be normal-to-mild
deranged in metastatic involvement. Considering the pro-
pensity for vascular invasion, with thyroid abnormalities, the
jugular system should be checked for tumor thrombus.r e f e r e n c e s
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